A government-sponsored study showed the drug shortens patients’ recovery times by 31 percent or an average of about four days.
On Friday, Food and Drug Administration (FDA) Commissioner Stephen Hahn said remdesivir, a broad-spectrum antiviral medication developed by the pharmaceutical company Gilead, is now authorized for emergency use on hospitalized patients with coronavirus.
While the drug hasn’t been officially approved by the FDA pending further study,White House Coronavirus Task Force member Dr. Anthony Fauci said the drug will now be a new standard of care for handling severely ill coronavirus patients.
